An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in ...
And though drugs that have some effect on Alzheimer’s disease, dementia’s most common manifestation, have recently been ...
A study of Roche's anti-amyloid drug gantenerumab has suggested that early treatment to remove amyloid plaques from the brain ...
Vaccination against shingles may reduce dementia risk, suggesting viral infections play a crucial role in Alzheimer’s disease ...
An experimental drug appears to reduce the risk of Alzheimer’s disease in people destined to develop the condition in middle ...
Alzheimer’s disease is the most common condition that causes problems with memory and thinking skills, which is to say that ...
During the early stages of the disease, the amyloid protein can build-up as plaques in the brain. Brain immune cells, called microglia, are located nearby amyloid plaques and become activated in the ...
A new study suggests that women who use a popular hormonal menopause treatment later in life may be at a higher risk of developing Alzheimer’s disease.
A new study has found that an experimental drug appears to reduce the risk of Alzheimer' s-related dementia in people ...
The findings provide new evidence to support the so-called amyloid hypothesis of Alzheimer’s disease, which posits that the first step on the road to dementia is the build-up of amyloid plaques ...
The findings provide new evidence to support the so-called amyloid hypothesis of Alzheimer's disease, which posits that the first step on the road to dementia is the build-up of amyloid plaques in ...